Sze Wah Samuel Chan

5PUBLICATIONS
54CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Jul 31, 2025
Leptomeningeal carcinomatosis presenting as catatonia.

Sze Wah Samuel Chan, Asghar Naqvi, Rosalyn Juergens

|Feb 20, 2025
The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study.

Sze Wah Samuel Chan, Gregory R Pond, John R Goffin

|Dec 06, 2024
Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.

Sze Wah Samuel Chan, Zainab Ali Amer Al Maqrashi, Jack Young

Pageof 1